ADITICKER
Analog Devices Inc.
Congress has disclosed 33 buys and 27 sells of ADI (Analog Devices Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
33
Buy
27
Sell
+6
Net
20
Active politicians
Round-trip watch Still on the books
Members who disclosed buying ADI and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Josh Gottheimer | 2026-05-19 | $411.92 | $423.73 | +2.9% | ↩ near entry |
| Rob Bresnahan | 2025-04-08 | $162.65 | $423.73 | +160.5% | in profit |
| Jared Moskowitz | 2025-04-07 | $167.79 | $423.73 | +152.5% | in profit |
| Alan Armstrong | 2026-03-27 | $305.67 | $423.73 | +38.6% | in profit |
| Rohit Khanna | 2026-04-13 | $347.99 | $423.73 | +21.8% | in profit |
Price as of 2026-11-02. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Technology. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/E
49.66
▲ pricier than
Technology (median 33.7)
how it's calculated
P/E = price ÷ earnings per share
$423.73 ÷ $8.53 = 49.66
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
6.12
≈ in line with
Technology (median 6.2)
how it's calculated
P/B = price ÷ book value per share
$423.73 ÷ $69.24 = 6.12
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Technology). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 7022 | Mystic Alerts Act | Science, Technology, Communications | 2026-10-22 |
| S 5663 | PROOF Act | Science, Technology, Communications | 2026-09-30 |
| SRES 923 | A resolution expressing support for the designation of October 4 through October 10, 2026, as "National 4-H Week". | Science, Technology, Communications | 2026-09-29 |
| HR 10610 | Stop Spam Calls Act | Science, Technology, Communications | 2026-09-24 |
| HR 10594 | Reliable Artificial Intelligence Research Act of 2026 | Science, Technology, Communications | 2026-09-24 |
60 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rick Larsen | House | BUY ◆ insider divergence | Self · Richard R Larsen IRA | 2026-10-08 | 4 days | +0.1% | $1K–$15K 0.7% of NW |
89.6 | ↗ filing |
| Sheldon Whitehouse | Senate | SELL ◆ insider convergence | Spouse | 2026-09-04 | 27 days | +11.7% | $1K–$15K | 97.9 | ↗ eFD |
| Richard Dean McCormick | House | SELL ◆ insider convergence | Self · Growth Partners Roth IRA | 2026-07-30 | 13 days | +4.8% | $1K–$15K 0.7% of NW |
89.4 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence | Self · Kean Family Partnership | 2026-06-30 | 1 days | -2.1% | $1K–$15K 0.1% of NW |
29.9 | ↗ filing |
| Richard Dean McCormick | House | SELL ◆ insider convergence | Self · Growth Partners Roth IRA | 2026-06-12 | 26 days | -7.8% | $1K–$15K 0.7% of NW |
85.0 | ↗ filing |
| Richard Dean McCormick | House | SELL ◆ insider convergence | Self · Growth Partners IRA | 2026-06-12 | 26 days | -7.8% | $1K–$15K 0.7% of NW |
85.0 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2026-05-19 | 14 days | +2.4% | $1K–$15K <0.1% of NW |
65.9 | ↗ filing |
| Thomas Kean | House | SELL ◆ insider convergence · moderate | Self · Kean Family Partnership | 2026-04-29 | 18 days | +7.2% | $1K–$15K 0.1% of NW |
18.7 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Spouse | 2026-04-13 | 21 days | +13.4% | $1K–$15K | 25.1 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider divergence · moderate | Self | 2026-03-27 | 116 days | +24.9% | $1K–$15K | 89.2 | ↗ eFD |
| Richard Dean McCormick | House | SELL ◆ insider convergence | Self · Growth Partners Roth IRA | 2026-03-19 | 19 days | +5.5% | $1K–$15K 0.7% of NW |
82.2 | ↗ filing |
| Richard Dean McCormick | House | SELL ◆ insider convergence | Self · Growth Partners IRA | 2026-03-19 | 19 days | +5.5% | $1K–$15K 0.7% of NW |
82.2 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence · moderate | Joint · Chase Brokerage Account (3935) | 2025-12-18 | 18 days | +0.9% | $1K–$15K <0.1% of NW |
13.7 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence · moderate | Joint · Chase Brokerage Account (3935) | 2025-11-13 | 22 days | +18.4% | $1K–$15K <0.1% of NW |
27.4 | ↗ filing |
| Richard Dean McCormick | House | BUY ◆ insider divergence · moderate | Self | 2025-11-05 | 34 days | +17.5% | $1K–$15K 0.7% of NW |
88.3 | ↗ filing |
| Julie Johnson | House | SELL ◆ insider convergence · moderate | Joint · Chase Brokerage Account (3935) | 2025-08-14 | 19 days | +5.5% | $1K–$15K <0.1% of NW |
62.7 | ↗ filing |
| Jefferson Shreve | House | SELL ◆ insider convergence | Self · CRT - Standard Unit Trust | 2025-05-12 | 3 days | +1.8% | $15K–$50K <0.1% of NW |
48.6 | ↗ filing |
| Thomas Kean | House | BUY ◆ insider divergence · moderate | Self · Kean Family Partnership | 2025-04-24 | 9 days | +1.7% | $1K–$15K 0.1% of NW |
54.9 | ↗ filing |
| Dan Newhouse | House | SELL ◆ insider convergence · moderate | Spouse · Edward Jones IRA | 2025-04-11 | 20 days | +8.1% | $1K–$15K <0.1% of NW |
26.9 | ↗ filing |
| Rob Bresnahan | House | BUY ◆ insider divergence · moderate | Self · JP Morgan Brokerage Account | 2025-04-08 | 0 days | 0.0% | $1K–$15K 0.2% of NW |
92.7 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Self · Morgan Stanley Active Assets (1) | 2025-04-07 | 23 days | +13.8% | $1K–$15K 0.3% of NW |
33.3 | ↗ filing |
| Jefferson Shreve | House | BUY ◆ insider divergence · moderate | Self · CRT - Standard Unit Trust | 2025-03-31 | 3 days | -10.3% | $15K–$50K <0.1% of NW |
95.8 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2025-03-12 | 26 days | -17.1% | $1K–$15K | 50.0 | ↗ filing |
| Thomas Kean | House | BUY ◆ insider divergence | Self · Kean Family Partnership | 2024-12-13 | 24 days | +0.6% | $1K–$15K 0.1% of NW |
66.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-11-15 | 19 days | +5.8% | $1K–$15K | 33.6 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence | Self · Morgan Stanley Active Assets (1) | 2024-11-08 | 22 days | -3.4% | $1K–$15K 0.3% of NW |
9.6 | ↗ filing |
| John James | House | SELL ◆ insider convergence | Self · John A. James Children’s Trust | 2024-09-04 | 1 days | -1.2% | $1K–$15K <0.1% of NW |
26.0 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-05-29 | 6 days | — | $1K–$15K | 22.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence · moderate | Child | 2024-04-26 | 5 days | — | $1K–$15K | 52.4 | ↗ filing |
| Dan Newhouse | House | BUY ◆ insider divergence · moderate | Spouse · Edward Jones IRA | 2024-04-10 | 0 days | — | $1K–$15K <0.1% of NW |
66.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2024-02-13 | 21 days | — | $1K–$15K | 75.9 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence | Child · Morgan Stanley Active Assets (5) | 2023-12-28 | 3 days | — | $1K–$15K 0.3% of NW |
8.6 | ↗ filing |
| John James | House | BUY ◆ insider divergence | Self · John A. James Children’s Trust | 2023-11-10 | 277 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| Greg Stanton | House | SELL ◆ insider convergence | Spouse | 2023-10-24 | 2 days | — | $1K–$15K 0.5% of NW |
40.4 | ↗ filing |
| Greg Stanton | House | BUY ◆ insider divergence | Spouse | 2023-09-26 | 25 days | — | $1K–$15K 0.5% of NW |
75.9 | ↗ filing |
| Lois Frankel | House | SELL ◆ insider convergence | Self · Morgan Stanley IRA - X142 | 2023-09-08 | 28 days | — | $1K–$15K 0.3% of NW |
8.6 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Self · Morgan Stanley Active Assets (1) | 2023-07-14 | 395 days | — | $1K–$15K 0.3% of NW |
10.6 | ↗ filing |
| Rick Larsen | House | SELL ◆ insider convergence · moderate | Self · Richard R Larsen IRA > Ameriprise SPS Managed Account | 2023-07-05 | 8 days | — | $1K–$15K 0.7% of NW |
75.9 | ↗ filing |
| Greg Landsman | House | SELL ◆ insider convergence · moderate | Joint · Rockefeller Capital Management (1) | 2023-05-30 | 436 days | — | $1K–$15K 0.6% of NW |
40.4 | ↗ filing |
| Greg Landsman | House | BUY ◆ insider divergence · moderate | Joint · Rockefeller Capital Management (1) | 2023-04-24 | 472 days | — | $1K–$15K 0.6% of NW |
86.8 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Self · Morgan Stanley Active Assets (1) | 2023-04-14 | 16 days | — | $1K–$15K 0.3% of NW |
33.6 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Child · Morgan Stanley Active Assets (6) | 2023-03-27 | 4 days | — | $1K–$15K 0.3% of NW |
93.1 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Self · Morgan Stanley Active Assets (1) | 2023-03-27 | 4 days | — | $1K–$15K 0.3% of NW |
93.1 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence · moderate | Child · Morgan Stanley Active Assets (5) | 2023-03-27 | 4 days | — | $1K–$15K 0.3% of NW |
93.1 | ↗ filing |
| Richard Dean McCormick | House | BUY ◆ insider divergence · moderate | Self · Growth Partners Roth IRA | 2023-03-15 | 26 days | — | $1K–$15K 0.7% of NW |
99.3 | ↗ filing |
| Lois Frankel | House | BUY ◆ insider convergence · moderate | Self · Morgan Stanley IRA - X142 | 2022-09-12 | 8 days | — | $1K–$15K 0.3% of NW |
10.6 | ↗ filing |
| Lois Frankel | House | SELL | Self · Morgan Stanley IRA - X142 | 2022-07-22 | 39 days | — | $1K–$15K 0.3% of NW |
15.7 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2020-02-20 | 12 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2019-07-30 | 0 days | — | $1K–$15K 0.3% of NW |
22.3 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2018-08-14 | 6 days | — | $1K–$15K | 15.7 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2018-08-13 | 4 days | — | $1K–$15K | 22.3 | ↗ filing |
| Alan Lowenthal | House | SELL | Spouse | 2018-08-10 | 4 days | — | $1K–$15K | 40.4 | ↗ filing |
| Alan Lowenthal | House | BUY | Spouse | 2017-12-04 | 7 days | — | $1K–$15K | 75.9 | ↗ filing |
| Thomas Rooney | House | SELL | Self | 2017-09-22 | 9 days | — | $1K–$15K | 15.7 | ↗ filing |
| Frank LoBiondo | House | SELL | Self | 2017-05-17 | 20 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2016-11-14 | 0 days | — | $1K–$15K 0.3% of NW |
52.4 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2016-11-02 | 30 days | — | $1K–$15K | 31.8 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2016-09-01 | 30 days | — | $1K–$15K | 40.4 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2016-06-01 | 30 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2016-01-20 | 0 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in ADI — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
19
Congress trades with insider convergence
27
…with insider divergence
357
Insider open-market trades
Of the congressional trades in ADI, 19 coincided with corporate insiders moving the same way within 60 days, and 27 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-11-02 | ROCHE VINCENT | C-suite | SELL 10b5-1 | $4.3M | ↗ EDGAR |
| 2026-10-20 | Puccio Richard C Jr | C-suite | SELL 10b5-1 | $584K | ↗ EDGAR |
| 2026-10-08 | Jain Vivek | C-suite | SELL | $1.3M | ↗ EDGAR |
| 2026-10-07 | STATA RAY | Director | SELL 10b5-1 | $135K | ↗ EDGAR |
| 2026-10-07 | STATA RAY | Director | SELL 10b5-1 | $196K | ↗ EDGAR |
| 2026-10-07 | STATA RAY | Director | SELL 10b5-1 | $93K | ↗ EDGAR |
| 2026-10-07 | STATA RAY | Director | SELL 10b5-1 | $20K | ↗ EDGAR |
| 2026-10-07 | STATA RAY | Director | SELL 10b5-1 | $96K | ↗ EDGAR |
| 2026-10-07 | STATA RAY | Director | SELL 10b5-1 | $27K | ↗ EDGAR |
| 2026-10-07 | STATA RAY | Director | SELL 10b5-1 | $11K | ↗ EDGAR |
| 2026-10-07 | Jain Vivek | C-suite | SELL | $820K | ↗ EDGAR |
| 2026-10-06 | Puccio Richard C Jr | C-suite | SELL 10b5-1 | $632K | ↗ EDGAR |
| 2026-10-06 | STATA RAY | Director | SELL 10b5-1 | $42K | ↗ EDGAR |
| 2026-10-06 | STATA RAY | Director | SELL 10b5-1 | $180K | ↗ EDGAR |
| 2026-10-06 | STATA RAY | Director | SELL 10b5-1 | $295K | ↗ EDGAR |
| 2026-10-06 | STATA RAY | Director | SELL 10b5-1 | $78K | ↗ EDGAR |
| 2026-10-02 | Jain Vivek | C-suite | SELL | $834K | ↗ EDGAR |
| 2026-10-02 | Nakamura Katsufumi | C-suite | SELL | $498K | ↗ EDGAR |
| 2026-10-01 | ROCHE VINCENT | C-suite | SELL 10b5-1 | $4.0M | ↗ EDGAR |
| 2026-09-22 | Puccio Richard C Jr | C-suite | SELL 10b5-1 | $573K | ↗ EDGAR |
| 2026-09-09 | STATA RAY | Director | SELL 10b5-1 | $57K | ↗ EDGAR |
| 2026-09-09 | STATA RAY | Director | SELL 10b5-1 | $134K | ↗ EDGAR |
| 2026-09-09 | STATA RAY | Director | SELL 10b5-1 | $168K | ↗ EDGAR |
| 2026-09-09 | STATA RAY | Director | SELL 10b5-1 | $130K | ↗ EDGAR |
| 2026-09-09 | STATA RAY | Director | SELL 10b5-1 | $26K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-11-02 | ROCHE VINCENT C-suite 10b5-1 | SELL | $4.3M |
| ◆ insider | 2026-10-20 | Puccio Richard C Jr C-suite 10b5-1 | SELL | $584K |
| Congress | 2026-10-08 | Rick Larsen | BUY | $1K–$15K |
| ◆ insider | 2026-10-08 | Jain Vivek C-suite | SELL | $1.3M |
| ◆ insider | 2026-10-07 | STATA RAY Director 10b5-1 | SELL | $135K |
| ◆ insider | 2026-10-07 | STATA RAY Director 10b5-1 | SELL | $196K |
| ◆ insider | 2026-10-07 | STATA RAY Director 10b5-1 | SELL | $93K |
| ◆ insider | 2026-10-07 | STATA RAY Director 10b5-1 | SELL | $20K |
| ◆ insider | 2026-10-07 | STATA RAY Director 10b5-1 | SELL | $96K |
| ◆ insider | 2026-10-07 | STATA RAY Director 10b5-1 | SELL | $27K |
| ◆ insider | 2026-10-07 | STATA RAY Director 10b5-1 | SELL | $11K |
| ◆ insider | 2026-10-07 | Jain Vivek C-suite | SELL | $820K |
| ◆ insider | 2026-10-06 | Puccio Richard C Jr C-suite 10b5-1 | SELL | $632K |
| ◆ insider | 2026-10-06 | STATA RAY Director 10b5-1 | SELL | $42K |
| ◆ insider | 2026-10-06 | STATA RAY Director 10b5-1 | SELL | $180K |
| ◆ insider | 2026-10-06 | STATA RAY Director 10b5-1 | SELL | $295K |
| ◆ insider | 2026-10-06 | STATA RAY Director 10b5-1 | SELL | $78K |
| ◆ insider | 2026-10-02 | Jain Vivek C-suite | SELL | $834K |
| ◆ insider | 2026-10-02 | Nakamura Katsufumi C-suite | SELL | $498K |
| ◆ insider | 2026-10-01 | ROCHE VINCENT C-suite 10b5-1 | SELL | $4.0M |
| ◆ insider | 2026-09-22 | Puccio Richard C Jr C-suite 10b5-1 | SELL | $573K |
| ◆ insider | 2026-09-09 | STATA RAY Director 10b5-1 | SELL | $57K |
| ◆ insider | 2026-09-09 | STATA RAY Director 10b5-1 | SELL | $134K |
| ◆ insider | 2026-09-09 | STATA RAY Director 10b5-1 | SELL | $168K |
FAQ Common questions
How much has Congress traded ADI?
33 disclosed buys and 27 sells of ADI (Analog Devices Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade ADI?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.